Cita APA

Makowski, K., Vigevani, L., Albericio Palomera, F., Valcárcel, J., & Álvarez Domingo, M. (2016). Sudemycin K: A synthetic anti-tumor splicing inhibitor variant with improved activity and versatile chemistry.

Citación estilo Chicago

Makowski, Kamil, Luisa Vigevani, Fernando Albericio Palomera, Juan Valcárcel, y Mercedes Álvarez Domingo. Sudemycin K: A Synthetic Anti-tumor Splicing Inhibitor Variant With Improved Activity and Versatile Chemistry. 2016.

Cita MLA

Makowski, Kamil, et al. Sudemycin K: A Synthetic Anti-tumor Splicing Inhibitor Variant With Improved Activity and Versatile Chemistry. 2016.